Marinus Pharmaceuticals to Present at Upcoming Medical and Investor Conferences
May 18 2022 - 9:00AM
Business Wire
Marinus Pharmaceuticals, Inc. (Nasdaq: MRNS), a pharmaceutical
company dedicated to the development of innovative therapeutics to
treat seizure disorders, today announced that management will
participate in the following investor and medical conferences in
May and June:
Citi Biotech Virtual Co-Panel Day May 18 at 3:30 p.m. ET.
This presentation will be closed to conference participants
only.
H.C. Wainwright Global Investment Conference Available on
demand starting May 24 at 7:00 a.m. ET. Webcast Link:
https://journey.ct.events/view/f447a79f-2d56-40f1-9924-e6b53707d9c1
Jefferies Global Healthcare Conference June 9 at 3:30
p.m. ET in New York, N.Y. Webcast Link:
https://wsw.com/webcast/jeff240/mrns/1869600
16th EILAT Conference on New Antiepileptic Drugs and
Devices May 22 – 25 in Madrid, Spain This event is closed to
conference participants only.
Epilepsy Foundation Pipeline Conference June 6 at 6:20
p.m. ET / 3:20 p.m. PT in Santa Clara, Calif. This presentation
will be closed to conference participants only.
About Marinus Pharmaceuticals Marinus is a pharmaceutical
company dedicated to the development of innovative therapeutics to
treat seizure disorders. Ganaxolone is a neuroactive steroid GABAA
receptor modulator that acts on a well-characterized target in the
brain known to have anti-seizure effects. It is being developed in
IV and oral dose formulations intended to maximize therapeutic
reach to adult and pediatric patient populations in both acute and
chronic care settings. For more information visit
www.marinuspharma.com.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20220518005448/en/
Sasha Damouni Ellis Vice President, Corporate Affairs &
Investor Relations Marinus Pharmaceuticals, Inc. 484-253-6792
sdamouni@marinuspharma.com
Marinus Pharmaceuticals (NASDAQ:MRNS)
Historical Stock Chart
From Aug 2024 to Sep 2024
Marinus Pharmaceuticals (NASDAQ:MRNS)
Historical Stock Chart
From Sep 2023 to Sep 2024